AzTrials
AzTrials

First AidNCT07773844

Using 360-Degree Interactive Video for Bleeding First Aid in Nursing Education: Effects on Knowledge, Self-Efficacy, and Learning Experience

A study testing 360-degree VR video simulation in people with First Aid and Hemorrhage, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a 360-degree interactive virtual reality (VR) video simulation works to improve first aid knowledge, knowledge retention, and self-efficacy in stopping severe bleeding among first-year undergraduate nursing students. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
First Aid, Hemorrhage, Nursing Education
What is being tested?
360-degree VR video simulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
152 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 May 2022to 2 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Being a volunteer participant
  • Being a first-year nursing student enrolled at Ege University Faculty of Nursing during the 2021-2022 academic year.
  • Having successfully completed the "First Aid Module" (First Aid Course) within the current curriculum

Who cannot join

  • Having any pre-existing health or visual conditions that prevent the safe use of virtual reality (VR) equipment (such as active epilepsy, severe uncorrected visual impairment, or pre-existing psychiatric disorders).
  • Requesting to withdraw from the study or refusing to participate at any stage of the research

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ege University Faculty of Nursing

    Izmir

Other trials in Turkey (Türkiye)

About this study

Official title: 360 Derece Etkileşimli Video Teknolojisinin Hemşirelik Eğitiminde Kullanımı: Bir Karma Yöntem Araştırması

The goal of this clinical trial is to learn if a 360-degree interactive virtual reality (VR) video simulation works to improve first aid knowledge, knowledge retention, and self-efficacy in stopping severe bleeding among first-year undergraduate nursing students. The main questions the study aims to answer are:

  • Does experiencing the interactive VR video simulation increase students' knowledge of bleeding first aid?
  • Does the VR video simulation increase students' long-term retention of first aid knowledge?
  • Does the VR video simulation improve students' self-efficacy in bleeding first aid? Researchers compared four groups using a Solomon four-group design to evaluate the effectiveness of the VR simulation, while also testing whether taking a pre-test affected the final outcomes.
Read more

Participants:

  • Completed an introductory survey and possibly a baseline test measuring first aid knowledge and self-efficacy.
  • Attended a 1-hour standard classroom lecture about first aid for bleeding.
  • (Intervention groups only) Completed a 5-minute interactive 360-degree video simulation of a severe bleeding emergency using an Oculus Quest 2 VR headset, which required answering 7 clinical decision-making questions.
  • Completed follow-up tests 4 weeks and 8 weeks after the training to measure their bleeding first aid knowledge and self-efficacy.
Being tested
360-degree VR video simulation
Medical subject headings
Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 360-degree VR video simulationOther

    A 5-minute interactive 360-degree video simulation of a severe bleeding emergency using an Oculus Quest 2 VR headset, which requires answering 7 clinical decision-making questions

Study groups in NCT07773844
Study groupRoleWhat they receive
Intervention Group 1 (Pre-tested)ExperimentalReceives the pre-test, standard classroom instruction (lecture), the 360-degree VR video simulation, the post-test, and the retention test
Receives: Other: 360-degree VR video simulation
Intervention Group 2 (Unpre-tested)ExperimentalReceives standard classroom instruction, the 360-degree VR video simulation, the post-test, and the retention test
Receives: Other: 360-degree VR video simulation
Control Group 1 (Pre-tested)No interventionReceives the pre-test, standard classroom instruction, the post-test, and the retention test
Control Group 2 (Unpre-tested)No interventionReceives standard classroom instruction, the post-test, and the retention test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bleeding First Aid Knowledge

    Assessed using the "First Aid for Bleeding Knowledge Test" developed and validated by the researchers. This is a 20-item multiple-choice test designed to measure cognitive learning. Correct answers are scored as 1 and incorrect answers as 0. The total score ranges from 0 to 20, with higher scores indicating higher levels of bleeding first aid knowledge.

    Measured: Baseline (Pre-test), 4 weeks post-intervention (Post-test), and 8 weeks post-intervention (Retention test)

  2. Bleeding First Aid Self-Efficacy

    Assessed using the "First Aid for Bleeding Self-Efficacy Scale" developed and validated by the researchers. This is a 19-item, five-point Likert-type scale (ranging from 1=completely insufficient to 5=completely sufficient) that measures students' perceived competence in managing bleeding situations. The total score ranges from 19 to 95, with higher scores reflecting greater clinical self-efficacy.

    Measured: Baseline (Pre-test) and 4 weeks post-intervention (Post-test)

Secondary outcomes (4)
  1. Perception of Simulation Design

    Assessed using the 20-item Simulation Design Scale (adapted into Turkish by Unver et al., 2017) only for the intervention groups. The scale evaluates five key elements of simulation design: objectives/information, student support, problem-solving, guided reflection/feedback, and fidelity. Items are rated on a five-point Likert scale (1=strongly disagree to 5=strongly agree). The overall score ranges from 20 to 100, where higher scores reflect a stronger presence of effective simulation design components.

    Measured: Immediately after the virtual reality simulation session

  2. Student Satisfaction and Self-Confidence in Learning

    Assessed using the 12-item Student Satisfaction and Self-Confidence in Learning Scale (adapted into Turkish by Unver et al., 2017). It includes two subscales: satisfaction with current learning (5 items) and self-confidence in learning (7 items). Items are rated on a five-point Likert scale (1=strongly disagree to 5=strongly agree). The total score ranges from 12 to 60, with higher scores indicating greater learning satisfaction and self-confidence.

    Measured: Immediately after the virtual reality simulation session

  3. Video Engagement and Immersion

    Assessed using the 15-item Video Engagement Scale (adapted into Turkish by Deryakulu et al., 2019) to measure the student's emotional and cognitive immersion. It consists of five subscales (attention, going into a narrative world, identity, empathy, and emotion) rated on a seven-point Likert scale (1=strongly disagree to 7=strongly agree). The total score ranges from 15 to 105, with higher scores indicating stronger engagement with the VR environment.

    Measured: Immediately after the virtual reality simulation session

  4. Occurrence of Cybersickness / Simulation Side Effects

    Assessed using a structured Researcher Observation Form to track any simulator-related physical discomfort (such as dizziness, nausea, headache, or neck pain) experienced by participants during or immediately after the VR headset experience. Side effects are recorded categorically as present/absent and graded by severity (none, mild, moderate).

    Measured: During and up to 15 minutes immediately following the virtual reality experience

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2026
  2. Study start10 May 2022
  3. Primary completion2 Aug 2022
  4. Study completion2 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study utilizes a Solomon four-group design to isolate the educational effects of the interactive 360-degree VR video simulation while systematically controlling for pre-test sensitization. Participants are randomly assigned to one of four parallel groups with different pre-testing and intervention conditions: Intervention Group 1 (Pre-tested): Receives the pre-test, standard classroom instruction (lecture), the 360-degree VR video simulation, the post-test (at 4 weeks), and the retention test (at 8 weeks) Intervention Group 2 (Unpre-tested): Receives standard classroom instruction, the 360-degree VR video simulation, the post-test, and the retention test without undergoing a pre-test Control Group 1 (Pre-tested): Receives the pre-test, standard classroom instruction, the post-test, and the retention test Control Group 2 (Unpre-tested): Receives standard classroom instruction, the post-test, and the retention test without undergoing a pre-test
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
152 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07773844
Sponsor's protocol ID
EGE-2021-11/04-1081
Status last verified
Aug 2026
First submitted
16 Aug 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing 360-degree VR video simulation in people with First Aid and Hemorrhage, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bleeding First Aid Knowledge (time frame: Baseline (Pre-test), 4 weeks post-intervention (Post-test), and 8 weeks post-intervention (Retention test)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in